Comments

Apimeds Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Apimeds Pharmaceuticals (APUS) operate in?

Apimeds Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

APUSAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.75

-0.06-3.31%

At close: -

Apimeds Pharmaceuticals (APUS) Forecast

News Earnings Apimeds Pharmaceuticals (APUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Apimeds Pharmaceuticals Stock Price, Quotes and Forecasts | AMEX:APUS | Benzinga

Explore Apimeds Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APUS.

Open	$1.81
Close	$1.75
Volume / Avg.	451.65K / 1.04M
Day Range	$1.44 - $1.83
52 Wk Range	1.72 - 4.00
Market Cap	$22.98M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	0
Short Interest	-
Days to Cover	-

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.81
Close	$1.75
Volume / Avg.	451.65K / 1.04M
Day Range	$1.44 - $1.83
52 Wk Range	1.72 - 4.00
Market Cap	$22.98M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	0
Short Interest	-
Days to Cover	-

About Apimeds Pharmaceuticals US Inc.

Sector

Health Care

Industry

Biotechnology

Apimeds Pharmaceuticals Us Inc is a clinical-stage company. It is engaged in a pharmaceutical busine...

Got Questions? Ask

What are analysts' targets for APUS?

What do APUS's technical indicators suggest?

What is APUS's net income trend?

What is the consensus rating for APUS?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Apimeds Pharmaceuticals (APUS) stock?

You can purchase shares of Apimeds Pharmaceuticals (AMEX:APUS) through any online brokerage.

View our list of the best stock brokerages

Who are Apimeds Pharmaceuticals (APUS) competitors?

Other companies in Apimeds Pharmaceuticals’s space includes: Curis (NASDAQ:CRIS), Burning Rock Biotech (NASDAQ:BNR), Nanoviricides (AMEX:NNVC), ABVC BioPharma (NASDAQ:ABVC) and Longeveron (NASDAQ:LGVN).

What is the forecast, or price target, for Apimeds Pharmaceuticals (APUS) stock?

There is no analysis for Apimeds Pharmaceuticals to provide a consensus price target.

What is the current price for Apimeds Pharmaceuticals (APUS)?

The stock price for Apimeds Pharmaceuticals (AMEX: APUS) is $1.75 last updated May 13, 2025 at 7:56 PM EDT.

Does Apimeds Pharmaceuticals (APUS) pay a dividend?

There are no upcoming dividends for Apimeds Pharmaceuticals.

When is Apimeds Pharmaceuticals (AMEX:APUS) reporting earnings?

Apimeds Pharmaceuticals does not have any upcoming earnings scheduled.

Is Apimeds Pharmaceuticals (APUS) going to split?

There is no upcoming split for Apimeds Pharmaceuticals.

What sector and industry does Apimeds Pharmaceuticals (APUS) operate in?

Apimeds Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.